The ease of acquiring prior authorizations for a new formulary drug plays a part in evaluating oncology drugs that are new to the market.
Andrea Iannucci, PharmD, BCOP
Advertisement
Assistant Chief Pharmacist, UC Davis Health
Articles by Andrea Iannucci, PharmD, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
COPD Deaths Rival Heart Failure, Exceed Prostate and Breast Cancer
2
AI Model Flags Colorectal Cancer on Routine Noncontrast CT Scans
3
FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations
4
Vutrisiran Effects Consistent With, Without Tafamidis in ATTR-CM
5